computer anti-virus info

Targeted Genetics Corporation (NASDAQ: TGEN) today announced the issuance of an additional patent related to its adeno-associated virus (AAV) vector technology that describes delivery of genes or delivery of small therapeutic genetic constructs or small therapeutic genetic constructs including therapeutic RNA molecules such as RNAi. U.S. patent #7,125,717 entitled "Metabolically Activated Recombinant Viral Vectors and Methods for Their Preparation and Use" describes the use of AAV vectors that are more efficient for expression of therapeutic genetic constructs.

Single stranded Deoxyribonucleic acid (DNA) vectors like AAV require conversion to a double-stranded DNA form in order for the therapeutic gene of interest to be expressed. The AAV virus DNA is about 4.7 Kb in size. However, a significant number of either genes used in gene therapy as well as genetic co...

Reflex Security®, Inc. (www.reflexsecurity.com), a pioneer and innovator in intrusion prevention systems (IPS), today announced IPS Everywhere™, a major initiative to accelerate the delivery of accurate and high-performance IPS protection throughout today's security-impelled enterprises.

"We see a gaping hole in competitors' IPS product offerings," said Jim Watson, CEO, Reflex Security. "Not only are existing IPS solutions difficult to work with, but many vendors are moving to multi-function security appliances, managed security services, and other expansions of their business before they've solved the most fundamental problems associated with preventing intrusions: accurate detection and enterprise-wide coverage." Over the next six months, Reflex Security will deploy its patented IPS solutions to protect the most vulnerable areas of today's enterprises:

Refle...